Table 3 Measles and rubella immunity status among different groups vaccinated with various vaccination schedules and their response to revaccination, East of Mazandaran province, North of Iran
Groups (n) birth date | GA: n = 98,1984–1998 | GB: n = 295,1999–2003 | GCa: n = 139,2004–2007 | GD: n = 103,2008–2011 | Total n = 635,1984–2011 |
|---|---|---|---|---|---|
vaccination status: | A | B | C | D | different schedules |
mMV: | + | + | – | – | |
MR: | + | – | – | – | |
MMR: | – | + one dose | +  2 doses | +  2 doses | |
Measles: | 96 (98%) | 250 (84.7%) | 123 (88.5%) | 88 (85.4%) | 557 (87.7%) |
Seroimmune n (%) MCA ± SD Response rate to revaccination respond/total(%) | 25.15 ± 6.47 | 17.63 ± 7.21 | 19.34 ± 7.02 | 17.17 ± 7.42 | 19.19 ± 7.59 |
– | 26/28(92.8%) | 11/12(91.6%) | 9/10(90%) | 46/50(92%) | |
Rubella: | 98(100%) | 221(74.9%) | 115(82.9%) | 84(81.55%) | 518(81.57%) |
Seroimmune n (%)MCA ± SD | 25.71 ± 2.29 | 23.07 ± 15.56 | 24.67 ± 12.51 | 20.09 ± 9.83 | 23.36 ± 13.14 |
Response rate to revaccination respond/ total(%) | – | 34/36(94.4%) | 15/16(93.7%) | 7/7(100%) | 56/59(94.3%) |